Lupin gets 2 observations from USFDA for Nagpur facility Medical Dialogues Bureau13 Jan 2020 11:58 AM ISTDrug firm Lupin on Saturday said it has received two observations from the US health regulator following the inspection of its Nagpur manufacturing...